AN2 THERAPEUTICS INC (ANTX)
US0373261058 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 15.65M | 27.20M | 12.10M | 4.10M | 5.60M | |||
| Marketable Securities | 91.65M | 68.80M | 46.50M | 0.00 | N/A | |||
| Other Current Assets | 3.21M | 2.60M | 1.60M | 200.00K | 100.00K | |||
| Total Current Assets | 110.51M | 98.60M | 60.10M | 4.20M | 5.70M | |||
| Non-Current Assets | ||||||||
| Investments And Advances | 27.19M | 3.20M | 3.50M | 0.00 | N/A | |||
| Other Non-Current Assets | 1.04M | 700.00K | 1.70M | 0.00 | N/A | |||
| Total Non-Current Assets | 28.24M | 4.00M | 5.20M | 0.00 | 0.00 | |||
| TOTAL ASSETS | 138.74M | 102.60M | 65.30M | 4.20M | 5.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 10.00K | N/A | |||
| Accrued Expenses | 10.70M | 5.10M | 2.30M | 1.30M | 100.00K | |||
| Accounts Payable | 2.68M | 2.10M | 1.10M | 100.00K | 100.00K | |||
| Other Current Liabilities | 668.00K | 0.00 | N/A | 0.00 | 0.00 | |||
| Total Current Liabilities | 14.04M | 7.20M | 3.40M | 1.50M | 200.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 0.00 | N/A | 0.00 | 700.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 700.00K | |||
| TOTAL LIABILITIES | 14.04M | 7.20M | 3.40M | 1.50M | 900.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -154.46M | -89.70M | -47.40M | -20.30M | -5.80M | |||
| Additional Paid In Capital | 278.88M | 185.50M | N/A | N/A | N/A | |||
| Common Shares | 300.00 | 0.00 | 109.30M | 23.10M | 10.60M | |||
| Other Shareholders' Equity | -300.00 | 0.00 | N/A | N/A | N/A | |||
| Shares Outstanding | 29.74M | 19.40M | 18.70M | 18.70M | 18.70M | |||
| Tangible Book Value per Share | 4.19 | 4.92 | -2.53 | -1.09 | -0.31 | |||
| Total Shareholders' Equity | 124.70M | 95.40M | 61.90M | 2.80M | 4.80M | |||
| TOTAL LIABILITIES AND EQUITY | 138.74M | 102.60M | 65.30M | 4.20M | 5.70M | |||
| Statistics | ||||||||
| Current Ratio | 7.87 | 13.69 | 17.68 | 2.80 | 28.50 | |||
| Return On Assets (ROA) | -46.66% | -41.70% | -42.97% | -347.14% | -100.53% | |||
| Return On Equity (ROE) | -51.91% | -44.84% | -45.33% | -520.71% | -119.38% | |||
All data in USD